CGPA (@CdnGenerics) header
CGPA (@CdnGenerics) profile picture

CGPA

@CdnGenerics

The Canadian Generic Pharmaceutical Association represents the generic #pharmaceutical industry in Canada. Support us in keeping Canadian #healthcare costs down

 Canada
canadiangenerics.ca
Joined August 2011
  • Tweets2.6K
  • Following1.9K
  • Followers3K
1KMedia
Photo by CGPA (@CdnGenerics)Photo by CGPA (@CdnGenerics)Photo by CGPA (@CdnGenerics)Photo by CGPA (@CdnGenerics)Photo by CGPA (@CdnGenerics)Photo by CGPA (@CdnGenerics)Photo by CGPA (@CdnGenerics)Photo by CGPA (@CdnGenerics)Photo by CGPA (@CdnGenerics)Photo by CGPA (@CdnGenerics)
Time for Action: Investing in Health Canada to Accelerate Access to Affordable Medications, Jim Keon writes nationalnewswatch.com/2025/1… @CdnGenerics
Time for Action: Investing in Health Canada to Accelerate Access to…

Time for Action: Investing in Health Canada to Accelerate Access to…

National Newswatch: Canada's most comprehensive site for political news and views.

nationalnewswatch.com
2
3
1,001
CAPDM and @CdnGenerics recently hosted a Multi-stakeholder Summit on Drug Shortages. Collaborated with many experts, incl. @GovCanHealth, @ONThealth, and @UofT to discuss actions. Stay tuned for insights and next steps! #CdnHealth #Pharmacy #SupplyChain #Collaboration
Image from Vital (@Vital_CDN)
Image from Vital (@Vital_CDN)
Image from Vital (@Vital_CDN)
Image from Vital (@Vital_CDN)
2
4
130
Delighted to speak with members of the Canadian Generic Pharmaceutical Association. CGPA members provide immeasurable contributions to our healthcare system, offering safe and cost-effective medicines to Ontarians, while contributing to our province's economy.
Image from Sylvia Jones (@SylviaJonesMPP)
Image from Sylvia Jones (@SylviaJonesMPP)
20
3
2
15
1,831
Shoring up domestic pharmaceutical production is key to maintaining a consistent supply of generic drugs in Canada. A new report from CGPA reveals the state of the sector and provides recommendations on boosting domestic production. Read more here: bit.ly/3LfeuYG
CGPA (@CdnGenerics) profile pictureCGPA
@CdnGenerics7 Feb 2022
An illuminating (and sometimes sobering) study by consulting firm EY Canada and commissioned by CGPA was just released today. How did our drug supply fair during the worst of the pandemic? How resilient are our domestic manufacturing industry and international supply chain? (1/2)
Image from CGPA (@CdnGenerics)
2
1
Médicaments génériques | La production locale est en baisse lapresse.ca/affaires/2022-02…
2
1
2
“We are used to assuming our health-care system is better than our friends to the south, but in reality, 🇺🇸s have over 90% of their prescription drugs filled through generics, whereas in 🇨🇦, we only have around 73%.” #cdnpoli #onpoli ⁦@CdnGenerics⁩ thestar.com/opinion/contribu…
1
2
Increasing the use of generic drugs is one anti-inflation tactic thestar.com/opinion/contribu… via @torontostar
1
1
Increasing the use of generic drugs is one anti-inflation tactic dlvr.it/SBNYYc #StarOpinion
2
1
Jean-Guy Goulet of Pharmascience Elected Chair of Canadian Generic Pharmaceutical Association (CGPA) @CdnGenerics bit.ly/37ETEQa
Image from CNWHealthcare (@CNWHealthcare)
4
5
Vaccine Debate Highlights Need for Canada to Ensure a More Secure Supply of Prescription Medicines urlzs.com/6ZFBV #COVID19 #CovidVaccine #CNDHealthcare #SupplyChains
Image from CGPA (@CdnGenerics)
1
1
Canada’s private payers bridged the gap and reached the same level of generic use as the public sector, how much would be saved? Contact your insurance provider to ask if you are taking full advantage of generic savings. #employeebenefits #economicrecovery
Image from CGPA (@CdnGenerics)
2
1
For #biosimilars information from Health Canada, visit: tinyurl.com/y3q3ez5j #GlobalBiosimilarsWeek #WhyBiosimilars #BiosimilarsBasics @GovCanHealth
FDA Drugs and Biologics (@FDADrugs) profile pictureFDA Drugs and Biologics
@FDADrugs18 Nov 2020
DYK? Biosimilars are safe and effective treatments for many illnesses. Check out FDA’s patient-friendly information to learn more: go.usa.gov/x7VPd #GlobalBiosimilarsWeek #WhyBiosimilars #BiosimilarBasics
Image from FDA Drugs and Biologics (@FDADrugs)
1
6
Interested in the cost saving associated with #Biosimilars, but need to know more about the evidence before adopting a new plan design? Read about our successful transition pilot: bit.ly/3fdC5JS #WhyBiosimilars #GlobalBiosimilarsWeek
3
5
More than 2 billion patient treatment days of experience with EU approved biosimilars and counting. Clinical experience with #biosimilars in Canada, the U.S., Australia and other jurisdictions continues to grow. #WhyBiosimilars #TrustBiosimilars #GlobalBiosimilarsWeek
Medicines for Europe (@medicinesforEU) profile pictureMedicines for Europe@medicinesforEU19 Nov 2020
Over 2️⃣ billion patient days of clinical experience with biosimilars is a lot of reasons why to #trustbiosimilars. Learn more about biosimilar safety and efficacy at bit.ly/IGBAGBW #GlobalBiosimilarsWeek
Image from Medicines for Europe (@medicinesforEU)
3
6
Our recent study, led by @UofTPharmacy student Michael Crosby, found annual savings up to $426M could be realized nationally if mandatory non-medical switch policies were introduced in Canada for #biosimilars + highlights important patient considerations: odprn.ca/research/publicatio…
Image from ODPRN (@ODPRN_Research)
4
9
An invitation to join the global conversation and learn more about #biosimilar medicines with #GlobalBiosimilarsWeek from Hanan Sboul, Chair of the International Generic and Biosimilar Medicines Association (IGBA). youtu.be/QnH8Ae8uO74
3
1
7
The first ever #GlobalBiosimilarsWeek starts today! This is a globally aligned educational initiative organized by the International Generic and Biosimilar Medicines Association to raise awareness of #biosimilars worldwide. Read more: igbamedicines.org/doc/IGBA%2…
Image from Biosimilars Canada | Biosimilaires Canada (@CDNBiosimilars)
1
4
What are #biosimilars? Learn the #BiosimilarBasics at bit.ly/IGBAGBW #DoYouKnowBiosimilars #GlobalBiosimilarsWeek
Image from Biosimilars Canada | Biosimilaires Canada (@CDNBiosimilars)
3
5
Biosimilars are biologic medicines that treat diseases like cancer, diabetes, inflammatory bowel disease and rheumatoid arthritis. Learn the #BiosimilarBasics at bit.ly/IGBAGBW #DoYouKnowBiosimilars #GlobalBiosimilarsWeek
Image from Biosimilars Canada | Biosimilaires Canada (@CDNBiosimilars)
3
6
How can biosimilars help improve patient access to biologic medicines? Join the conversation on social media November 16-20 by following #GlobalBiosimilarsWeek at bit.ly/IGBAGBW
Image from GreenShield (@GreenShieldCo)
4
5
Load more